Pulmonary Arterial Hypertension in France

Abstract

This contemporary registry highlights current practice and shows that PAH is detected late in the course of the disease, with a majority of patients displaying severe functional and hemodynamic compromise.

Keywords

MedicineVascular resistancePulmonary hypertensionCardiac indexCohortIncidence (geometry)Pulmonary arteryPopulationInternal medicineBlood pressurePediatricsCardiologySurgeryCardiac output

Affiliated Institutions

Related Publications

Survival in pulmonary hypertension in Spain: insights from the Spanish registry

Pilar Escribano Subías , Isabel Blanco , Manuel López‐Meseguer +7 more

A pulmonary hypertension (PH) registry (Spanish Registry of Pulmonary Arterial Hypertension) was undertaken to analyse prevalence, incidence and survival of pulmonary arterial h...

2012 European Respiratory Journal 401 citations

An epidemiological study of pulmonary arterial hypertension

A. Peacock , Niamh Murphy , John J.V. McMurray +2 more

All hospitalisations for pulmonary arterial hypertension (PAH) in the Scottish population were examined to determine the epidemiological features of PAH. These data were compare...

2007 European Respiratory Journal 790 citations

Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Gérald Simonneau , David Montani , David S. Celermajer +5 more

Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 m...

2018 European Respiratory Journal 3642 citations

Pulmonary arterial hypertension in patients treated with interferon

Laurent Savale , C.H. Sattler , Sven Günther +11 more

Isolated cases of pulmonary arterial hypertension (PAH) in patients treated with interferon (IFN) α or β have been reported in the literature. The aim of this study was to descr...

2014 European Respiratory Journal 103 citations

Pulmonary hypertension associated with benfluorex exposure

Laurent Savale , Marie‐Camille Chaumais , Vincent Cottin +17 more

Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of pulmonary arterial hype...

2012 European Respiratory Journal 90 citations

Publication Info

Year: 2006
Type: article
Volume: 173
Issue: 9
Pages: 1023-1030
Citations: 1978
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Pulmonary Arterial Hypertension in France

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1978

OpenAlex

Cite This

APA Style

                            
                                
                                    Marc Humbert, 
                                
                                    Olivier Sitbon, 
                                
                                    Ari Chaouat
                                
                                et al.
                            
                            (2006). 
                            Pulmonary Arterial Hypertension in France. 
                            American Journal of Respiratory and Critical Care Medicine
                            , 173
                            (9)
                            , 1023-1030.
                            https://doi.org/10.1164/rccm.200510-1668oc
                        

Identifiers

DOI: 10.1164/rccm.200510-1668oc